NCT04912635 is a NA clinical trial of Neo App in Sleep Apnea, Obstructive, sponsored by ResMed.

Who is sponsoring NCT04912635?

NCT04912635 is sponsored by ResMed.

What drugs are being tested in NCT04912635?

Interventions in NCT04912635: Neo App.

What condition does NCT04912635 study?

NCT04912635 studies Sleep Apnea, Obstructive.

Is NCT04912635 still recruiting?

NCT04912635 is currently completed. Last updated 3 June 2021.

Last reviewed 2021-06-03 · How we verify

NCT04912635

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation of a Health Dashboard Intervention to Improve Engagement With CPAP Therapy in PAP-Naïve Patients: Project Neo

Completed NA Last updated 3 June 2021

What this trial tests

NA trial testing Neo App in Sleep Apnea, Obstructive in 300 participants. Completed in 25 March 2021.

Timeline

25 September 2020

Primary endpoint
19 December 2020

25 March 2021

Quick facts

Lead sponsor	ResMed
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	single group
Masking	none
Primary purpose	other
Enrollment	300
Start date	25 September 2020
Primary completion	19 December 2020
Estimated completion	25 March 2021
Sites	1 location across Australia

Drugs / interventions tested

Neo App

Conditions studied

Sleep Apnea, Obstructive — all drugs for Sleep Apnea, Obstructive →

Sponsor

ResMed — full company profile →

Who can join

18 and older, any sex, with Sleep Apnea, Obstructive. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a prospective, open-label study to evaluate the effectiveness of providing a dashboard with merged health metrics of CPAP (continuous positive airway pressure/ PAP) usage, self-reported sleepiness, blood pressure (BP) and activity (steps).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Sleep Apnea, Obstructive

Currently open trials in the same condition.

NCT06828835 — The REPOSE (Reach for Equity in Pediatric Sleep Evaluation) Navigation Intervention · NA · recruiting
NCT06915831 — Type 1 Diabetes and Obstructive Sleep Apnea · NA · recruiting
NCT07176767 — The IPAD Cohort Study: Insomnia and Positive Airway Pressure Adherence in Children and Adolescents · recruiting
NCT06573372 — Evaluating the Diagnostic Efficacy of Smartwatch and Smartphone for Sleep Apnea · recruiting
NCT06848647 — Treatment of Sleep Apnea to Improve Metabolic Health · recruiting

Other ResMed trials

Trials by the same sponsor.

NCT07400861 — Study of Min-Max APAP Recommender Tool · NA · not yet recruiting
NCT07099183 — Nyx3 Data Collection Study · not yet recruiting
NCT06930404 — Data Collection Study to Review Novel Methods for Diagnosing Obstructive Sleep Apnea · not yet recruiting
NCT05255744 — Whitsundays (Nasal) Singapore External Clinical Study 1 Protocol · NA · unknown
NCT03924817 — Registry Study on Prescription, Patient Pathways, Therapy Efficacy and Usage of Mandibular Advancement Devices in Obstru · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04912635 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by ResMed
Last refreshed: 3 June 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04912635.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing